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Background-Aim. Upper extremity deep vein thrombosis (UEDVT) is an increasingly recognized problem in the critically ill. We
sought to identify the prevalence of and risk factors for UEDVT, and to characterize sonographically detected thrombi in the
critical care setting. Patients and Methods. Three hundred and twenty patients receiving a subclavian or internal jugular central
venous catheter (CVC) were included. When an UEDVT was detected, therapeutic anticoagulation was started. Additionally,
a standardized ultrasound scan was performed to detect the extent of the thrombus. Images were interpreted oﬄine by two
independent readers. Results. Thirty-six (11.25%) patients had UEDVT and a complete scan was performed. One (2.7%) of these
patients died, and 2 had pulmonary embolism (5.5%). Risk factors associated with UEDVT were presence of CVC [(odds ratio
(OR) 2.716, P = 0.007)], malignancy (OR 1.483, P = 0.036), total parenteral nutrition (OR 1.399, P = 0.035), hypercoagulable
state (OR 1.284, P = 0.045), and obesity (OR 1.191, P = 0.049). Eight thrombi were chronic, and 28 were acute. We describe
a new sonographic sign which characterized acute thrombosis: a double hyperechoic line at the interface between the thrombus
and the venous wall; but its clinical signiﬁcance remains to be deﬁned. Conclusion. Presence of CVC was a strong predictor for the
development of UEDVT in a cohort of critical care patients; however, the rate of subsequent PE and related mortality was low.
1.Introduction
Upper extremity deep venous thrombosis (UEDVT) may be
underdiagnosed as imaging of these vessels is not a rou-
tine part of pulmonary embolism (PE) investigation [1].
M o r e o v e r ,P Ei st h o u g h tt oo c c u ra tl o wr a t e s( 7t o9 % )
in patients with UEDVT [1–3]. The clinical signiﬁcance of
UEDVT remains uncertain and much variability in reported
treatment [4]. Nevertheless, current guidelines recommend
that UEDVT should be treated similarly to lower extremity
deep venous thrombosis [5]. In various series, 35 to 75%
of patients who have upper extremity, neck, or torso central
venous catheters (CVCs) develops thrombosis, with 75% be-
ing asymptomatic [6–10]. CVCs have been increasingly used
in the intensive care unit (ICU) hence there is rationale
to further investigated UEDVT [11–15]. CVC-associated
UEDVT may be related to the material the catheter is made
of and its diameter [11–17]. Other commonly reported risk
factors for development of UEDVT are malignancy and
thrombophilia. Less frequently reported risk factors include
an obstructing tumor, pregnancy, and estrogen use [1, 18–
21]. However, it is diﬃcult to ﬁnd extensive data on the
incidence and clinical characteristics of UEDVT in the ICU
[9, 10, 12].
The situation is further complicated by the use of
diﬀerent imaging techniques to diagnose UEDVT such as
radionuclide scanning, ultrasound, magnetic resonance
imaging (MRI), computed tomography (CT), and contrast2 Critical Care Research and Practice
venography. Venography remains the reference standard but
cannot be used readily in the critically ill and has a small
incidence of complications [10, 22]. Ultrasonography is con-
sideredtheinitialimagingtestofchoiceasitcanexcludedeep
venousthrombosisandidentifyproximalvenousobstruction
[1, 3, 8–11, 21, 23]. The advantages of this test include its
noninvasiveness, portability, lack of ionizing radiation, and
high sensitivity and speciﬁcity [23].
Inthisstudy,weaimedtoclarifytheclinicaluncertainties
andriskfactorsassociatedwiththediagnosisandsigniﬁcance
of UEDVT by retrospectively analyzing ultrasound data de-
rived from a cohort of critical care patients. Moreover, we
analyzed the sonographic features of detected thromboses in
order to assess thrombus age.
2.MaterialsandMethods
We extracted data from the archives of previously regis-
tered trials, which were conducted by our team and con-
cerned subclavian (SCV) and internal jugular vein (IJV)
ultrasound-guided cannulation (ISRCTN-61258470) [24,
25]. The present study was approved by the General State
Hospital of Athens ethical committee. Three hundred and
twenty critical care patients, who were hospitalized in a mul-
tipur-pose intensive care unit (ICU) from 2006 to 2012,
a n di nw h o mc o m p l e t es o n o g r a p h i cr e c o r d sw e r ea v a i l a b l e
for retrieval, were enrolled. All patients were sedated and
mechanically ventilated (Servo-I ventilator, Maquet Inc.,
Bridgewater, NJ, USA). All patients were routinely scanned
before, during and after ultrasound-guided IJV and SCV
cannulation by means of a portable HD11 XE ultrasound
machine(Philips,Andover,MA,USA)equippedwithahigh-
resolution 7.5–12MHz transducer, as described in detail
elsewhere[1,2].WhenanUEDVTwasidentiﬁed,acomplete
scanning protocol was initiated [23, 26]. In brief, the IJV
was examined from the level of the mandible to the point
at which it traveled under the clavicle. The junction of the
SCV and IJV originating at the innominate vein is diﬃcult to
visualize, therefore Doppler was utilized to provide indirect
information regarding the patency of the veins in this area.
Next, the SCV was followed in the direction of the clavicle
distally until it anatomically changed to the axillary vein,
which in turn was followed in the direction of the upper
arm where the brachial vein was identiﬁed. The latter was
followed distally until the junction of the radial and ulnar
veins, which in turn were followed until the region of the
wrist. Thus, a complete assessment of the deep veins of the
upper extremity and torso was completed. Ultrasound scan-
ning included utilization of two-dimensional (2D) scanning
with compression testing and Color-Doppler modes. Venous
thromboseswereidentiﬁedaccordingtoAmericanCollegeof
Radiology criteria [23].
All ultrasound data were stored in a computerized oﬀ-
line system. Sonographic images were reviewed retrospec-
tively by one independent radiologist and one intensivist
trained in vascular ultrasound, both of whom were blinded
to the subjects’ clinical characteristics. When a visible intra-
luminal thrombuswasidentiﬁed, severalof its characteristics
were evaluated to determine its relative age. Sonographic
features suggesting chronic thrombosis were a contracted
venous segment, thrombus adherence to the venous wall,
hyperechoic and heterogeneous appearance of the clot, par-
tial recanalization of the vessel, and presence of venous
collaterals. Features suggestive of acute thrombosis were
venous distention, a partially compressible or noncompress-
ible lumen, hypoechoic, homogeneous appearance of clots,
and presence of free ﬂoating thrombi [26–35]. UEDVT was
characterized either as spontaneous if no intravascular cath-
eters were related to the thrombus or as CVC associated
[1, 8, 9, 21, 24]. The segmental location of thrombosis was
analyzed according to the aﬀected veins (IJV, SCV, innom-
inate, axillary and brachial veins). All ultrasound images
were analytically reviewed to investigate whether any other
sonographic ﬁndings related to thrombosis age existed.
Clinicalparametersincluded:patientage,diagnosisupon
admission, days of hospitalization, CVC insertion location,
type of CVC (triple lumen, double-lumen catheter used for
hemodialysis), other indwelling vascular devices (i.e., pace-
makers), administration of total parenteral nutrition (TPN),
known anatomic vascular anomaly and hypercoagulable dis-
order, untreated coagulopathy, increased (≥35kg/m2)b o d y
mass index (BMI), and known malignancy [1, 2, 8, 12, 14–
21].Useofprophylactictreatmentwithlowmolecularweight
heparin (LMWH) and subsequent incidence of PE and ICU
death was investigated [1–3]. Moreover, we analyzed the
sonographic features of recorded thrombosis in an eﬀort to
assess the relative age of the thrombus.
3.StatisticalAnalysis
Continuous data were expressed as mean ± standard devia-
tion (SD). The student’s t-test or Fisher’s exact test was used
as appropriate to compare group means for patient data.
A two-sided P value of <0.05 was considered signiﬁcant.
Agreement between the two observers in the evaluation
of sonographic data was evaluated by Cohen’s weighted
κ, with 2.5th and 97.5th percentiles of 5,000 bootstrap
replicates estimated, using 95% conﬁdence intervals [13].
Multivariate logistical regression in determining potential
risk factors facilitating the development of UEDVT, as well
as all other statistical analyses, was performed using the
R2.10.1statisticalpackage(RDevelopmentCoreTeam,2009.
R: A language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria).
4. Results
Demographic and clinical characteristics of the total study
population are presented in Table 1. Thirty-six cases of
UEDVT were recorded out of 320 patients reviewed
(11.25%). The vast majority of patients in this cohort were
trauma victims. All patients had CVC inserted and received
prophylactic treatment with LMWH (Table 1).
Clinical and sonographic characteristics of the 36 cases
identiﬁed with UEDVT are shown in Table 2.U E D V Tw a s
most commonly observed in the SCV and IJV sites, while
the number of veins involved was usually 1 to 3. The
vast majority of UEDVTs recorded were CVC-associatedCritical Care Research and Practice 3
Table 1: Baseline characteristics of the study population.
Characteristics Patients n = 320
Age (years) 51 ± 15.5
Gender (male/female ratio) 0.52 ± 0.4
APACHE II score 20.2 ± 3.1
Diagnosis upon admission
Trauma 205 (64%)
Burn 12 (3.75%)
ARDS 26 (8.12%)
Sepsis 48 (15%)
Postsurgical complications 29 (9.13%)
Body mass index (kg/m2) 27.2 ± 10.3
Anatomic vascular abnormality (%) 6 (1.87%)
Untreated coagulopathy (%) 0 (0%)
Prophylactic treatment with LMWH (%) 320 (100%)
Hypercoagulable state (%) 16 (5%)
Malignancy (%) 23 (7.18%)
Total number of UEDVT (%) 36 (11.25%)
Central venous catheters 177 (55.3%)
Other intravascular devices 16 (5%)
Days of hospitalization 59 ± 26
Abbreviations are: APACHE II: acute physiology and chronic health
evaluation score; ARDS: acute respiratory distress syndrome; LMWH:
low molecular weight heparin; UEDVT: upper extremity deep venous
thrombosis.
thromboses (91.7%). Acute thromboses (77.8%) were more
commonly observed compared to chronic ones (Table 2)
(Figures 1 and 2). UEDVT was mainly symptomatic (55.6%)
presenting with edema (20/20) and erythema (5/20) of
the aﬀected extremity; however, some asymptomatic cases
were noted (Table 2). Other factors that also predisposed
to thromboses such as obesity, TPN, and malignancy;
these parameters are presented in Table 2. Six of the 9
thromboses associated with TPN were catheter associated.
Eight cases of thrombophilia were recorded in patients with
UEDVT, which were attributed to mutations of factor V and
prothrombingene(6cases)andtoproteinCandSdeﬁciency
(2 cases), following laboratory investigation. Notably, only
two cases of subsequent PE (5.5%) and one death were
recorded in patients with UEDVT (Table 2). All critical care
patientswithUEDVTreceivedfullanticoagulationtreatment
(unfractionated or LMWH) with no side eﬀects noted.
Table 3 presents the typical sonographic features of
UEDVT as registered by the two independent observers. Clot
adherence to the venous wall, partial recanalization of the
lumen, and presence of venous collaterals was associated
with chronic thrombosis; while free-ﬂoating thrombi with
echolucent and homogeneous appearance, lack of compress-
ibilityanddistendedveinswereobservedinacutethrombosis
(Figures 1 and 2). Notably, in 20 out of 28 cases of acute
thrombosis a double hyperechoic line along the thrombus
and wall interface was identiﬁed (Table 3, Figure 3). The
overall agreement between the two observers who reviewed
Table 2: Characteristics of the 36 cases with upper extremity deep
venous thrombosis (UEDVT).
Characteristics Number (percent)
Location of UEVT
Internal jugular vein 25
Subclavian vein 27
Innominate vein 9
Axillary vein 11
Brachial 6
Number of venous segments involved
Single segment 14
Two segments 12
Three segments 10
Four segments 4
Five segments 2
Clinical characteristics
Spontaneous thrombosis 3 (8.3%)
Catheter-associated thrombosis 33 (91.7%)∗
Triple-lumen catheter 14 (38.8%)
Hemodialysis (double-lumen catheter) 19 (52.7%)
Malignancy 14 (38.8%)
Hypercoagulable state 8 (22.2%)
T o t a lp a r e n t e r a ln u t r i t i o n 9( 2 5 % )
Body mass index ≥35kg/m2 8 (22.2%)
Asymptomatic thrombosis 16 (44.4%)
Symptomatic thrombosis 20 (55.6%)
Subsequent pulmonary embolism 2 (5.5%)
ICU deaths 1 (2.7%)
Therapeutic anticoagulation 36 (100%)
General sonographic characteristics
Acute thrombosis 28 (77.8%)∗∗
Chronic thrombosis 8 (12.2%)
∗Catheter-associated versus spontaneous thrombosis and
∗∗acute versus chronic thrombosis (both P<0.01; Fisher’s test).
the sonographic ﬁndings was signiﬁcant (κ = 0.88, 95%
conﬁdence intervals by bootstrap analysis = 0.85–0.93, P<
0.02).
Multivariate logistic regression analysis (Table 4) identi-
ﬁed that insertion of CVC (both triple lumen and double-
lumen catheters for hemodialysis), administration of TPN;
presence of malignancy, presence of thrombophilia as well as
body mass index ≥35kg/m2 were all signiﬁcantly correlated
with the occurrence of UEDVT (all P<0.05). Notably,
insertion of CVC was the factor with the strongest eﬀect
upon the incidence of UEDVT (odds ratio = 2.716, 95%
conﬁdence intervals = 2.312–2.911; P = 0.007).
5. Discussion
A rate of 11.25% of UEDVT in patients being examined for
CVC placement was detected in this study, consistent with
previously published series [1, 2, 9, 20, 21, 36]. Ultrasound4 Critical Care Research and Practice
SCV
(a)
(b) (c)
Figure 1: Leftsubclavian vein catheter-associated chronic thrombosiswith partialrecanalization (a);proximalrightinternal jugular vein (b)
and ipsilateral subclavian vein (c) with associated collateral ﬂow (arrow) in a patient with chronic spontaneous thrombosis. SCV: Subclavian
Vein.
(a)
RAV middle 1/3 Press
(b)
Thrombus
3-lumen
catheter
(c)
Thrombus
3-lumen catheter
(d)
Figure 2: Incompressible proximal right and medial left axillary veins (arrows) in two cases of spontaneous acute thrombosis, respectively
((a), (b)); two cases of catheter-associated thrombosis of the right internal jugular vein with fresh clots obstructing almost totally the venous
lumen (c); one of the three lumens of the catheter (in this case delivering total parenteral nutrition, (d)).Critical Care Research and Practice 5
(a) (b)
(c)
Figure 3: Double hyperechoic line along fresh thrombus/wall interface (arrows) in limited segments of the subclavian vein ((a), (b)) and in
extended segments of the left brachial vein (panoramic view with zoom, (c)).
Table 3: Estimating the relative age of venous thrombus by
ultrasound.
Characteristics Number/total cases
Chronic thrombosis (n = 8)
Contracted venous segment 6/8
Clot adherence 8/8
Free-ﬂoating thrombi 1/8
Hyperechoic thrombi 4/8
Homogeneous thrombi 1/8
Partial recanalization 7/8
Venous collaterals 7/8
Acute thrombosis (n = 28)
Venous distention 22/28
Lumen partially and/or noncompressible 26/28
Hypoechoic thrombi 18/28
Homogeneous thrombi 22/28
Free-ﬂoating thrombi 20/28
Double hyperechoic line 20/28
along the thrombus/wall interface
was able to diagnose UEDVT and a high agreement was reg-
istered between the two independent observers as previously
suggested [8, 11, 22, 23, 26, 28–30, 32, 36]. The sensitivity of
Doppler sonography in the diagnosis for UEDVT has been
reported to range from 78% to 100% and its speciﬁcity from
82% to 100% in various series [8–11, 22, 23, 32, 36]. Our
results add to the prior literature on detection of UEDVT in
ICU patients.
The subsequent rate of PE was on the low end of
previously published data [1–4, 12, 20, 21, 36, 37]. The
reasonsforthisarenotentirelyclear;however,wenotethatin
this study, allpatients withUEDVT werefullyanticoagulated
as per recommended guidelines [5]. Notably, in the study
of Mustafa et al., all patients with symptomatic UEDVT
received anticoagulant therapy and none developed PE [9].
However, despite guideline recommendations, prescribing
full anticoagulation for UEDVT remains controversial [1–3].
The highest risk for UEDVT was having a CVC. Of note,
these were all critically ill patients who were being exam-
ined for CVC insertion. Risk factors have been established
for catheter-related DVT which include catheter material,
diameter, and position of the catheter. Clinical and in vitro
studies have demonstrated that both polyurethane and
silicone catheters are associated with a lower rate of catheter-
relatedDVTascomparedwithpolyethyleneorTeﬂon-coated
catheters [16, 17] .I no u rs t u d ya l lC V C sw e r ep o l y u r e t h a n e .
The pathogenesis of thrombosis is multifactorial and
ICU patients may have a higher incidence of risk factors
than the general population. We conﬁrmed previously pub-
lished data which suggested that obesity, malignancy, a hy-
percoagulable state, and administration of TPN are potential
risk factors for UEDVT [9, 12, 14, 15, 37, 38]. Obesity may6 Critical Care Research and Practice
Table 4: Multivariate logistical regression correlating various parameters with the incidence of upper extremity deep venous thrombosis.
Eﬀect
Odds ratio estimates
Point estimate 95% conﬁdence limits P
Central venous catheter 2.716 2.312–2.911 0.007
Triple lumen catheter 1.515 1.108–2.166 0.035
Hemodialysis (double-lumen) catheter 1.823 1.245–2.344 0.024
Malignancy 1.483 1.107–1.746 0.036
Total parenteral nutrition 1.399 1.066–1.699 0.042
Hypercoagulable state 1.284 1.108–1.382 0.045
Body mass index ≥35kg/m2 1.191 1.079–1.402 0.049
predispose to DVT via several mechanisms, including the
physical eﬀects of body fat inhibiting venous return as well
as endocrine changes and changes in signaling molecules.
Obesity is a proinﬂammatory, prothrombotic, and hypoﬁb-
rinolytic state with increased concentrations of coagulation
factors and plasminogen activator inhibitor-1 [39]. Out of
the 9 patients who had thromboses associated with TPN, 6
were catheter associated. Infusion of TPN may be irritating
to veins causing vascular injury and inﬂammation that is
prothrombotic [40].
It is increasingly noted that venous thrombosis is as-
sociated with an inﬂammatory response which plays an
essential role in both formation and resolution. This could
explain why ICU patients are at higher risk of thrombosis.
Thrombus generation is dependent on adhesion molecules
such as the selectin family. These molecules are critical for
recruitment and attachment of inﬂammatory cells and ﬁbrin
deposition within the thrombus. The mechanism of delivery
of the components necessary for thrombus formation is via
microparticles shed from the plasma membrane of various
cells.Leukocytesandcytokinesassociatedwithinﬂammation
are also essential to angiogenesis and ﬁbrinolysis of throm-
bus resolution. Outlining the inﬂammatory mechanisms
involved in the genesis and resolution response may lead to
potential treatments for venous thromboembolism. Current
anticoagulation therapies primarily that prevent thrombus
propagation are associated with bleeding risk, and do not
directly modulate the associated inﬂammation [41–46].
We also found that the most common location of
UEDVT was in the IJV and SCV sites as observed by others
[1, 2, 7, 9, 10, 12, 18, 20, 36, 37] and that UEDVT may
involve several venous segments [1, 2, 9, 10, 12, 37]. Since
femoral catheters were not placed in this study, our data
do not challenge prior evidence that femoral CVCs have the
highest thrombotic risk [47].
In addition to detecting thromboses, ultrasound facili-
tated the estimation of the relative age of clots in this co-
hort. Cases of acute thrombosis were more commonly ob-
served than cases of chronic thrombosis. Clot adherence to
the venous wall, partial recanalization of the lumen, and
presence of venous collaterals were commonly observed in
chronic thrombosis; while free-ﬂoating thrombi with ech-
olucent and homogeneous appearance as well as noncom-
pressible,distendedveinswereobservedinacutethrombosis,
respectively [26–30].
We also described a new sonographic sign in 2D images
that was present in 20 out of 28 cases of acute thrombosis: a
double hyperechoic line at the interface between the throm-
bus and the venous wall. Histology studies show that a
smooth coat of ﬁbrin lines the external surface of an acute
thrombus [48]. The latter are three-dimensional networks
of ﬁbrin ﬁbers stabilized by factor XIIIa. Fibrin ﬁbers are
long,thinﬁbersthateasilybendratherthanstretch;however,
ﬁbrin itself is very dense and stiﬀ thus exhibiting high
acoustic impedance [26–30]. We speculate that this double
hyperechoic line might represent ﬁbrin ﬁbers coating acute
clots. If conﬁrmed in other studies, this ﬁnding may assist in
determining thrombus age. Recently, Rubin et al. suggested
that sonographic elasticity imaging, a technique measuring
tissue hardness, can discriminate between acute and chronic
thrombi [49, 50].
There were several limitations in this study. First, the
study was performed retrospectively solely in patients receiv-
ing a CVC and may not be extrapolated to all critically
ill patients. Second, ultrasound is an operator-dependent
technique, and the amount of training required to become
facile at upper extremity DVT examination is unknown.
Third, there were a small number of cases of UEDVT,
conﬁrming previously reported studies. The small numbers
precluded subgroup analyses. However, despite the small
n u m b e r sw ew e r ea b l et oﬁ n dv a r i o u sp a r a m e t e r st h a t
were signiﬁcantly related to thrombosis. Fourth, our cohort
consisted of a high percentage of trauma patients which may
aﬀectthegeneralizabilityofourﬁndings.Furtherprospective
studies would be required to conﬁrm that a strategy of
universal anticoagulation is correct for all ICU patients with
this problem.
6. Conclusions
ThepresentstudycharacterizedtheincidenceofUEDVTina
mixed ICU population. We conﬁrmed risk factors associated
with UEDVT including presence of a CVC, BMI > 35, a
hypercoagulable state, malignancy, and use of TPN. We
have fully characterized the locations, extent, and ultrasound
ﬁndings of UEDVTs in an ICU population. In this study, a
clinical strategy of universal anticoagulation led to favorable
outcomes. We also describe a new ultrasound ﬁnding of
acute thrombosis: a double hyperechoic line at the interface
between the thrombus and the venous wall. Further studiesCritical Care Research and Practice 7
are required to document the utility of this sign as well as the
best methods to diagnose and treat UEDVT in ICU patients.
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